Value proposition

We provide drug developers with data of outstanding quality to give them confidence to expedite new healthcare solutions

At Antibody Analytics we believe that scientists deserve the best data, and patients deserve the best drugs. Led by a group of talented and engaged scientists, we look at biological problems in an openminded way to deliver beautifully designed, developed and qualified bioassays.

We have developed a comprehensive portfolio of assays and platforms that can be tailored to support even the most complex of drug pipelines. Whether designing and developing bespoke bioassays or offering routine analysis on our already established assay platforms, Antibody Analytics has an exceptional track record of delivering beautiful results.

http://www.antibodyanalytics.com


Bioassays, ADCC, mAbs, ADCs, Bi-specifics, Biosimilars, Immuno-oncology, Method development, t cell activation, t cells, tumor microenvironment, TDCC, cell line development, checkpoint inhibitors, immunology, immunotherapeutics, antibodytherapeutics, immune cell engagers, CRO, services, biologics, NK cells, macrophages, dendritic cells, drug development, CAR-T, drug discovery, cell therapy, and Tregs